Metabolic syndrome (MetS) represents a cluster of cardiovascular and metabolic risk factors, including hypertension, abdominal obesity, dyslipidaemia and hyperglycaemia, which predispose individuals ...
MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo ...